Lorcaserin Extended-Release Tablets and Plasma-Lyte 56 and Dextrose
Determining the interaction of Lorcaserin Extended-Release Tablets and Plasma-Lyte 56 and Dextrose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: lvp solution with potassium
Brand name:
Synonyms: Dextrose and Electrolyte No 48
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Platinol
- Lorcaserin Extended-Release Tablets-Platinol-AQ
- Lorcaserin Extended-Release Tablets-Plavix
- Lorcaserin Extended-Release Tablets-Plazomicin
- Lorcaserin Extended-Release Tablets-Plazomicin Intravenous
- Lorcaserin Extended-Release Tablets-Plazomicin Sulfate
- Plasma-Lyte 56 and Dextrose-Lorcaserin Hydrochloride
- Plasma-Lyte 56 and Dextrose-Lorcaserin Tablets
- Plasma-Lyte 56 and Dextrose-Lorcet
- Plasma-Lyte 56 and Dextrose-Lorcet Plus
- Plasma-Lyte 56 and Dextrose-Lorcet Tablets
- Plasma-Lyte 56 and Dextrose-Lorlatinib